$9.19−0.55 (−5.65%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
908 Devices (MASS) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineSteady: revenue compounds ~7.4%/yr (FY21→FY25), net margin 34.7%; free cash flow runs at −126% of net income. Check the accrual gap. Worth your attention in FY25: Share count (+28.4%) and Capex step-up ($955.0K). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲17.7%
56.2
FY21→FY25CAGR +7.4%/yr
Net income ($M)—
19.5
FY21→FY25CAGR —
Free cash flow ($M)▲20.1%
−24.6
capex stepped upCAGR —
Diluted EPS—
0.54
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+28.4%
28.0mn → 35.9mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex step-up
$955.0K
▲59% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
35¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 55.0% → 50.6%. Net margin 34.7% is more than double the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 65,785.0 | 56,197.0 | 47,746.0 | 50,229.0 | 46,852.0 | 42,206.0 | ▲17.7% | +7.4% |
Cost of revenue | 31,389.0 | 27,774.0 | 23,246.0 | 24,907.0 | 20,829.0 | 18,973.0 | ▲19.5% | +10.0% |
Gross profit | 34,396.0 | 28,423.0 | 24,500.0 | 25,322.0 | 26,023.0 | 23,233.0 | ▲16.0% | +5.2% |
Research & development | 14,392.0 | 15,575.0 | 14,988.0 | 21,904.0 | 17,526.0 | 13,067.0 | ▲3.9% | +4.5% |
Selling, general & admin | 41,824.0 | 38,528.0 | 39,462.0 | 46,069.0 | 43,879.0 | 32,235.0 | ▼2.4% | +4.6% |
Total operating expenses | 62,476.0 | 67,844.0 | 81,893.0 | 68,080.0 | 61,405.0 | 45,302.0 | ▼17.2% | +10.6% |
Operating incomefeeds ROC rank | −28,080.0 | −39,421.0 | −57,393.0 | −42,758.0 | −35,382.0 | −22,069.0 | ▲31.3% | — |
Other income, net | 15,715.0 | 6,078.0 | 4,253.0 | 6,148.0 | 1,819.0 | −100.0 | — | — |
Pretax income | −12,365.0 | −33,343.0 | −53,140.0 | −36,610.0 | −33,563.0 | −22,169.0 | ▲37.3% | — |
Income tax | — | −66.0 | 0.0 | −211.0 | 0.0 | — | — | — |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | −24,254.0 | 19,489.0 | −72,206.0 | −36,399.0 | −33,563.0 | −22,169.0 | — | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.64 | 0.54 | −2.12 | −1.13 | −1.07 | −0.79 | — | — |
Diluted shares (mn) | 37.88 | 35.90 | 34.08 | 32.24 | 31.49 | 27.96 | ▲5.3% | +6.4% |
| Margins | ||||||||
Gross margin27th pct in Healthcare | 52.3% | 50.6% | 51.3% | 50.4% | 55.5% | 55.0% | ▼0.7pp | −4.5pp |
Operating margin | −42.7% | −70.1% | −120.2% | −85.1% | −75.5% | −52.3% | ▲50.1pp | −17.9pp |
Net margin95th pct in Healthcare | −36.9% | 34.7% | −151.2% | −72.5% | −71.6% | −52.5% | ▲185.9pp | +87.2pp |
† TTM = the four most recent quarters we hold, through 2026-09-30, added together. This column is our own sum rather than a restated trailing statement, so a quarter restated after it was filed is not reflected in it.
1 more year of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-03-09 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was 908 Devices' revenue last fiscal year?
908 Devices reported revenue of $56.2M in fiscal 2025, up 17.7% from fiscal 2024.
What was 908 Devices' net income?
908 Devices reported net income of $19.5M in fiscal 2025, a net margin of 34.7%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

